Cangene Corporation赞助的临床试验
总计8517个结果
-
The Lymphoma Academic Research OrganisationCelgene Corporation主动,不招人滤泡性淋巴瘤西班牙, 加拿大, 法国, 澳大利亚, 意大利, 比利时, 德国, 葡萄牙
-
Medical University of South CarolinaCelgene Corporation完全的
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation完全的
-
OncoMed Pharmaceuticals, Inc.Celgene Corporation完全的胰腺癌美国, 加拿大, 英国, 西班牙, 澳大利亚, 比利时
-
OncoMed Pharmaceuticals, Inc.Celgene Corporation完全的肺非鳞状非小细胞肿瘤西班牙, 美国, 澳大利亚, 意大利, 比利时
-
OncoMed Pharmaceuticals, Inc.Celgene Corporation完全的
-
Scripps HealthBristol-Myers Squibb; Celgene Corporation撤销白血病 | 慢性淋巴细胞白血病
-
Jason Robert GotlibCelgene Corporation终止白血病 | 贫血 | 骨髓增生异常综合征 (MDS) | 急性髓系白血病 (AML)美国
-
UNC Lineberger Comprehensive Cancer CenterCelgene Corporation终止
-
University of California, San DiegoCelgene Corporation撤销
-
Peking Union Medical College HospitalCelgene Corporation完全的
-
University of Kansas Medical CenterCelgene Corporation终止
-
Vaishali SanchorawalaCelgene Corporation完全的
-
GERCOR - Multidisciplinary Oncology Cooperative...Celgene Corporation未知
-
University Hospitals Cleveland Medical CenterCelgene Corporation完全的
-
University of Southern CaliforniaAstraZeneca; Celgene Corporation完全的
-
MD Anderson International Spain SACelgene Corporation完全的
-
University of California, San FranciscoCelgene Corporation完全的
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene Corporation未知
-
Washington University School of MedicineCelgene Corporation主动,不招人头颈癌 | 头颈部鳞状细胞癌 | 头颈癌 | 头颈肿瘤 | 头颈癌 | 癌,头颈部鳞状细胞美国
-
University of California, San DiegoCelgene Corporation完全的
-
Washington University School of MedicineCelgene Corporation主动,不招人
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation完全的
-
Washington University School of MedicineCelgene Corporation完全的
-
University of Kansas Medical CenterCelgene Corporation完全的
-
The Lymphoma Academic Research OrganisationCelgene Corporation完全的
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation撤销
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation未知
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation主动,不招人原发性骨髓纤维化 | 骨髓纤维化 | 真性红细胞增多症后澳大利亚, 奥地利, 比利时, 中国, 捷克语, 法国, 德国, 匈牙利, 意大利, 大韩民国, 荷兰, 波兰, 俄罗斯联邦, 西班牙, 爱尔兰, 英国
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的原发性骨髓纤维化 | 骨髓纤维化 | 真性红细胞增多症后骨髓纤维化 | 原发性血小板增多症后骨髓纤维化美国, 加拿大
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation可用的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的
-
GenMont Biotech IncorporationBiomedical Development Corporation完全的
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.; Celgene Corporation主动,不招人
-
Ohio State UniversityUniversity of Michigan; Celgene Corporation终止
-
Weill Medical College of Cornell UniversityCelgene Corporation终止
-
The Methodist Hospital Research InstituteNovartis; Celgene Corporation完全的
-
German Breast GroupRoche Pharma AG; Celgene Corporation完全的炎性乳腺癌 | HER-2阳性乳腺癌 | 管状乳腺癌 II 期 | 粘液性乳腺癌 II 期 | 乳腺癌女性 NOS | 浸润性导管癌 | 管状乳腺癌 III 期 | 炎性乳腺癌 IV 期德国
-
Jonsson Comprehensive Cancer CenterCelgene Corporation; CTI BioPharma终止